I run technology development at the Ludwig Institute, a program that supports all aspects of scientific, clinical and business development required to build additional validation into Ludwig’s scientific discoveries. Enhancing or de-risking Ludwig’s inventions in this way leads to greater opportunities for partnership and ultimately ensures further development of our most promising technologies. Establishing collaborative and licensing relationships with not-for-profit or commercial partners is a critical process in moving Ludwig technologies into the clinic where they might benefit cancer patients. I have completed numerous partnering transactions with biopharma companies, including several Ludwig start-up biotechnology companies that I have been instrumental in establishing, to develop different Ludwig technologies. I am also the Deputy Director of the Ludwig San Diego Branch. I received a PhD in Immunology from University College London and completed further research at the University of Virginia and the University of Oxford.
Ludwig Institute for Cancer Research, San Diego
9500 Gilman Drive,
Cellular and Molecular Medicine East Building
La Jolla, California, U.S. 92093-0670
T 858 534 7802
F 858 534 7750